nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—Rectal tenesmus—Imiquimod—skin cancer	0.0447	0.0467	CcSEcCtD
Valrubicin—Ageusia—Vismodegib—skin cancer	0.039	0.0407	CcSEcCtD
Valrubicin—Proctalgia—Imiquimod—skin cancer	0.0355	0.0371	CcSEcCtD
Valrubicin—Anorectal discomfort—Imiquimod—skin cancer	0.0304	0.0318	CcSEcCtD
Valrubicin—Local reaction—Imiquimod—skin cancer	0.03	0.0314	CcSEcCtD
Valrubicin—Blood urea increased—Vismodegib—skin cancer	0.0298	0.0312	CcSEcCtD
Valrubicin—TOP2A—Sorafenib—Vismodegib—skin cancer	0.0252	0.584	CbGdCrCtD
Valrubicin—Local reaction—Bleomycin—skin cancer	0.0213	0.0223	CcSEcCtD
Valrubicin—Skin irritation—Fluorouracil—skin cancer	0.0212	0.0222	CcSEcCtD
Valrubicin—TOP2A—Paclitaxel—Docetaxel—skin cancer	0.018	0.416	CbGdCrCtD
Valrubicin—Local reaction—Fluorouracil—skin cancer	0.0166	0.0173	CcSEcCtD
Valrubicin—Back pain—Vismodegib—skin cancer	0.0134	0.014	CcSEcCtD
Valrubicin—Myalgia—Vismodegib—skin cancer	0.0118	0.0123	CcSEcCtD
Valrubicin—Cystitis noninfective—Bleomycin—skin cancer	0.0115	0.0121	CcSEcCtD
Valrubicin—Irritability—Imiquimod—skin cancer	0.0115	0.012	CcSEcCtD
Valrubicin—Urinary retention—Imiquimod—skin cancer	0.0115	0.012	CcSEcCtD
Valrubicin—Cystitis—Bleomycin—skin cancer	0.0114	0.0119	CcSEcCtD
Valrubicin—Bladder pain—Bleomycin—skin cancer	0.0107	0.0112	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Vismodegib—skin cancer	0.0103	0.0107	CcSEcCtD
Valrubicin—Dysuria—Imiquimod—skin cancer	0.00976	0.0102	CcSEcCtD
Valrubicin—Oedema peripheral—Vemurafenib—skin cancer	0.00965	0.0101	CcSEcCtD
Valrubicin—Urinary incontinence—Temozolomide—skin cancer	0.00963	0.0101	CcSEcCtD
Valrubicin—Gastrointestinal pain—Vismodegib—skin cancer	0.00921	0.00963	CcSEcCtD
Valrubicin—Urinary tract infection—Imiquimod—skin cancer	0.00905	0.00945	CcSEcCtD
Valrubicin—Abdominal pain—Vismodegib—skin cancer	0.00891	0.00931	CcSEcCtD
Valrubicin—Back pain—Vemurafenib—skin cancer	0.00825	0.00862	CcSEcCtD
Valrubicin—Ageusia—Docetaxel—skin cancer	0.00818	0.00855	CcSEcCtD
Valrubicin—Asthenia—Vismodegib—skin cancer	0.00808	0.00845	CcSEcCtD
Valrubicin—Pruritus—Vismodegib—skin cancer	0.00797	0.00833	CcSEcCtD
Valrubicin—Diarrhoea—Vismodegib—skin cancer	0.00771	0.00806	CcSEcCtD
Valrubicin—Myalgia—Vemurafenib—skin cancer	0.00726	0.00759	CcSEcCtD
Valrubicin—Vomiting—Vismodegib—skin cancer	0.00716	0.00749	CcSEcCtD
Valrubicin—Rash—Vismodegib—skin cancer	0.0071	0.00742	CcSEcCtD
Valrubicin—Dermatitis—Vismodegib—skin cancer	0.0071	0.00742	CcSEcCtD
Valrubicin—Back pain—Imiquimod—skin cancer	0.00703	0.00735	CcSEcCtD
Valrubicin—Ill-defined disorder—Imiquimod—skin cancer	0.00675	0.00705	CcSEcCtD
Valrubicin—Nausea—Vismodegib—skin cancer	0.00669	0.00699	CcSEcCtD
Valrubicin—Pneumonia—Bleomycin—skin cancer	0.00665	0.00695	CcSEcCtD
Valrubicin—Malaise—Imiquimod—skin cancer	0.00656	0.00685	CcSEcCtD
Valrubicin—Irritability—Fluorouracil—skin cancer	0.00636	0.00665	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00634	0.00663	CcSEcCtD
Valrubicin—Haematuria—Bleomycin—skin cancer	0.0063	0.00659	CcSEcCtD
Valrubicin—Pneumonia—Dactinomycin—skin cancer	0.0062	0.00648	CcSEcCtD
Valrubicin—Chest pain—Imiquimod—skin cancer	0.00619	0.00647	CcSEcCtD
Valrubicin—Myalgia—Imiquimod—skin cancer	0.00619	0.00647	CcSEcCtD
Valrubicin—Discomfort—Imiquimod—skin cancer	0.00612	0.00639	CcSEcCtD
Valrubicin—Dysuria—Temozolomide—skin cancer	0.00585	0.00611	CcSEcCtD
Valrubicin—Pollakiuria—Temozolomide—skin cancer	0.00578	0.00604	CcSEcCtD
Valrubicin—Hyperglycaemia—Temozolomide—skin cancer	0.00564	0.0059	CcSEcCtD
Valrubicin—Pneumonia—Temozolomide—skin cancer	0.00561	0.00586	CcSEcCtD
Valrubicin—Body temperature increased—Vemurafenib—skin cancer	0.0055	0.00575	CcSEcCtD
Valrubicin—Urinary tract infection—Temozolomide—skin cancer	0.00542	0.00567	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00541	0.00565	CcSEcCtD
Valrubicin—Pneumonia—Fluorouracil—skin cancer	0.00517	0.0054	CcSEcCtD
Valrubicin—Urinary tract infection—Fluorouracil—skin cancer	0.00499	0.00522	CcSEcCtD
Valrubicin—Asthenia—Vemurafenib—skin cancer	0.00499	0.00522	CcSEcCtD
Valrubicin—Oedema peripheral—Temozolomide—skin cancer	0.00493	0.00515	CcSEcCtD
Valrubicin—Pruritus—Vemurafenib—skin cancer	0.00492	0.00515	CcSEcCtD
Valrubicin—Feeling abnormal—Imiquimod—skin cancer	0.00489	0.00511	CcSEcCtD
Valrubicin—Gastrointestinal pain—Imiquimod—skin cancer	0.00485	0.00507	CcSEcCtD
Valrubicin—Ill-defined disorder—Bleomycin—skin cancer	0.00479	0.00501	CcSEcCtD
Valrubicin—Anaemia—Bleomycin—skin cancer	0.00478	0.00499	CcSEcCtD
Valrubicin—Diarrhoea—Vemurafenib—skin cancer	0.00476	0.00498	CcSEcCtD
Valrubicin—Abdominal pain—Imiquimod—skin cancer	0.00469	0.0049	CcSEcCtD
Valrubicin—Body temperature increased—Imiquimod—skin cancer	0.00469	0.0049	CcSEcCtD
Valrubicin—Malaise—Bleomycin—skin cancer	0.00466	0.00487	CcSEcCtD
Valrubicin—Dizziness—Vemurafenib—skin cancer	0.0046	0.00481	CcSEcCtD
Valrubicin—Ill-defined disorder—Dactinomycin—skin cancer	0.00447	0.00467	CcSEcCtD
Valrubicin—Anaemia—Dactinomycin—skin cancer	0.00445	0.00465	CcSEcCtD
Valrubicin—Vomiting—Vemurafenib—skin cancer	0.00443	0.00463	CcSEcCtD
Valrubicin—Chest pain—Bleomycin—skin cancer	0.0044	0.0046	CcSEcCtD
Valrubicin—Myalgia—Bleomycin—skin cancer	0.0044	0.0046	CcSEcCtD
Valrubicin—Rash—Vemurafenib—skin cancer	0.00439	0.00459	CcSEcCtD
Valrubicin—Dermatitis—Vemurafenib—skin cancer	0.00438	0.00458	CcSEcCtD
Valrubicin—Headache—Vemurafenib—skin cancer	0.00436	0.00456	CcSEcCtD
Valrubicin—Discomfort—Bleomycin—skin cancer	0.00435	0.00454	CcSEcCtD
Valrubicin—Malaise—Dactinomycin—skin cancer	0.00435	0.00454	CcSEcCtD
Valrubicin—Asthenia—Imiquimod—skin cancer	0.00426	0.00445	CcSEcCtD
Valrubicin—Back pain—Temozolomide—skin cancer	0.00422	0.00441	CcSEcCtD
Valrubicin—Pruritus—Imiquimod—skin cancer	0.0042	0.00439	CcSEcCtD
Valrubicin—Nausea—Vemurafenib—skin cancer	0.00413	0.00432	CcSEcCtD
Valrubicin—Myalgia—Dactinomycin—skin cancer	0.0041	0.00429	CcSEcCtD
Valrubicin—Diarrhoea—Imiquimod—skin cancer	0.00406	0.00424	CcSEcCtD
Valrubicin—Discomfort—Dactinomycin—skin cancer	0.00405	0.00424	CcSEcCtD
Valrubicin—Ill-defined disorder—Temozolomide—skin cancer	0.00404	0.00423	CcSEcCtD
Valrubicin—Anaemia—Temozolomide—skin cancer	0.00403	0.00421	CcSEcCtD
Valrubicin—Malaise—Temozolomide—skin cancer	0.00393	0.00411	CcSEcCtD
Valrubicin—Dizziness—Imiquimod—skin cancer	0.00392	0.0041	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00384	0.00402	CcSEcCtD
Valrubicin—Vomiting—Imiquimod—skin cancer	0.00377	0.00394	CcSEcCtD
Valrubicin—Rash—Imiquimod—skin cancer	0.00374	0.00391	CcSEcCtD
Valrubicin—Dermatitis—Imiquimod—skin cancer	0.00374	0.00391	CcSEcCtD
Valrubicin—Pneumonia—Docetaxel—skin cancer	0.00373	0.0039	CcSEcCtD
Valrubicin—Headache—Imiquimod—skin cancer	0.00372	0.00389	CcSEcCtD
Valrubicin—Anaemia—Fluorouracil—skin cancer	0.00371	0.00388	CcSEcCtD
Valrubicin—Myalgia—Temozolomide—skin cancer	0.00371	0.00388	CcSEcCtD
Valrubicin—Discomfort—Temozolomide—skin cancer	0.00367	0.00383	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00358	0.00374	CcSEcCtD
Valrubicin—Nausea—Imiquimod—skin cancer	0.00353	0.00368	CcSEcCtD
Valrubicin—Feeling abnormal—Bleomycin—skin cancer	0.00347	0.00363	CcSEcCtD
Valrubicin—Myalgia—Fluorouracil—skin cancer	0.00342	0.00357	CcSEcCtD
Valrubicin—Chest pain—Fluorouracil—skin cancer	0.00342	0.00357	CcSEcCtD
Valrubicin—Discomfort—Fluorouracil—skin cancer	0.00338	0.00353	CcSEcCtD
Valrubicin—Body temperature increased—Bleomycin—skin cancer	0.00333	0.00348	CcSEcCtD
Valrubicin—Oedema peripheral—Docetaxel—skin cancer	0.00328	0.00343	CcSEcCtD
Valrubicin—Feeling abnormal—Dactinomycin—skin cancer	0.00324	0.00339	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00324	0.00339	CcSEcCtD
Valrubicin—Gastrointestinal pain—Dactinomycin—skin cancer	0.00322	0.00336	CcSEcCtD
Valrubicin—Abdominal pain—Dactinomycin—skin cancer	0.00311	0.00325	CcSEcCtD
Valrubicin—Body temperature increased—Dactinomycin—skin cancer	0.00311	0.00325	CcSEcCtD
Valrubicin—Asthenia—Bleomycin—skin cancer	0.00303	0.00316	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00299	0.00312	CcSEcCtD
Valrubicin—Pruritus—Bleomycin—skin cancer	0.00298	0.00312	CcSEcCtD
Valrubicin—Feeling abnormal—Temozolomide—skin cancer	0.00293	0.00306	CcSEcCtD
Valrubicin—Gastrointestinal pain—Temozolomide—skin cancer	0.00291	0.00304	CcSEcCtD
Valrubicin—Asthenia—Dactinomycin—skin cancer	0.00282	0.00295	CcSEcCtD
Valrubicin—Abdominal pain—Temozolomide—skin cancer	0.00281	0.00294	CcSEcCtD
Valrubicin—Body temperature increased—Temozolomide—skin cancer	0.00281	0.00294	CcSEcCtD
Valrubicin—Back pain—Docetaxel—skin cancer	0.0028	0.00293	CcSEcCtD
Valrubicin—Feeling abnormal—Fluorouracil—skin cancer	0.0027	0.00282	CcSEcCtD
Valrubicin—Diarrhoea—Dactinomycin—skin cancer	0.00269	0.00281	CcSEcCtD
Valrubicin—Vomiting—Bleomycin—skin cancer	0.00268	0.0028	CcSEcCtD
Valrubicin—Anaemia—Docetaxel—skin cancer	0.00268	0.0028	CcSEcCtD
Valrubicin—Rash—Bleomycin—skin cancer	0.00266	0.00278	CcSEcCtD
Valrubicin—Dermatitis—Bleomycin—skin cancer	0.00266	0.00278	CcSEcCtD
Valrubicin—Body temperature increased—Fluorouracil—skin cancer	0.00259	0.00271	CcSEcCtD
Valrubicin—Asthenia—Temozolomide—skin cancer	0.00255	0.00267	CcSEcCtD
Valrubicin—Pruritus—Temozolomide—skin cancer	0.00252	0.00263	CcSEcCtD
Valrubicin—Nausea—Bleomycin—skin cancer	0.0025	0.00262	CcSEcCtD
Valrubicin—Vomiting—Dactinomycin—skin cancer	0.0025	0.00261	CcSEcCtD
Valrubicin—Rash—Dactinomycin—skin cancer	0.00248	0.00259	CcSEcCtD
Valrubicin—Chest pain—Docetaxel—skin cancer	0.00247	0.00258	CcSEcCtD
Valrubicin—Myalgia—Docetaxel—skin cancer	0.00247	0.00258	CcSEcCtD
Valrubicin—Diarrhoea—Temozolomide—skin cancer	0.00243	0.00254	CcSEcCtD
Valrubicin—Dizziness—Temozolomide—skin cancer	0.00235	0.00246	CcSEcCtD
Valrubicin—Nausea—Dactinomycin—skin cancer	0.00234	0.00244	CcSEcCtD
Valrubicin—Pruritus—Fluorouracil—skin cancer	0.00232	0.00242	CcSEcCtD
Valrubicin—Vomiting—Temozolomide—skin cancer	0.00226	0.00236	CcSEcCtD
Valrubicin—Rash—Temozolomide—skin cancer	0.00224	0.00234	CcSEcCtD
Valrubicin—Diarrhoea—Fluorouracil—skin cancer	0.00224	0.00234	CcSEcCtD
Valrubicin—Dermatitis—Temozolomide—skin cancer	0.00224	0.00234	CcSEcCtD
Valrubicin—Headache—Temozolomide—skin cancer	0.00223	0.00233	CcSEcCtD
Valrubicin—Dizziness—Fluorouracil—skin cancer	0.00217	0.00227	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00216	0.00225	CcSEcCtD
Valrubicin—Nausea—Temozolomide—skin cancer	0.00211	0.00221	CcSEcCtD
Valrubicin—Vomiting—Fluorouracil—skin cancer	0.00208	0.00218	CcSEcCtD
Valrubicin—Rash—Fluorouracil—skin cancer	0.00207	0.00216	CcSEcCtD
Valrubicin—Dermatitis—Fluorouracil—skin cancer	0.00206	0.00216	CcSEcCtD
Valrubicin—Headache—Fluorouracil—skin cancer	0.00205	0.00215	CcSEcCtD
Valrubicin—Feeling abnormal—Docetaxel—skin cancer	0.00195	0.00204	CcSEcCtD
Valrubicin—Nausea—Fluorouracil—skin cancer	0.00195	0.00203	CcSEcCtD
Valrubicin—Gastrointestinal pain—Docetaxel—skin cancer	0.00193	0.00202	CcSEcCtD
Valrubicin—Body temperature increased—Docetaxel—skin cancer	0.00187	0.00195	CcSEcCtD
Valrubicin—Abdominal pain—Docetaxel—skin cancer	0.00187	0.00195	CcSEcCtD
Valrubicin—Asthenia—Docetaxel—skin cancer	0.0017	0.00177	CcSEcCtD
Valrubicin—Pruritus—Docetaxel—skin cancer	0.00167	0.00175	CcSEcCtD
Valrubicin—Diarrhoea—Docetaxel—skin cancer	0.00162	0.00169	CcSEcCtD
Valrubicin—Dizziness—Docetaxel—skin cancer	0.00156	0.00163	CcSEcCtD
Valrubicin—Vomiting—Docetaxel—skin cancer	0.0015	0.00157	CcSEcCtD
Valrubicin—Rash—Docetaxel—skin cancer	0.00149	0.00156	CcSEcCtD
Valrubicin—Dermatitis—Docetaxel—skin cancer	0.00149	0.00156	CcSEcCtD
Valrubicin—Headache—Docetaxel—skin cancer	0.00148	0.00155	CcSEcCtD
Valrubicin—Nausea—Docetaxel—skin cancer	0.00141	0.00147	CcSEcCtD
